Cart
sales@molnova.com
Doxycycline monohydrate
CAS No. 17086-28-1
Doxycycline monohydrate( —— )
Catalog No. M21369 CAS No. 17086-28-1
Doxycycline monohydrate is an inhibitor of metalloproteinase (MMP).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 39 | Get Quote |
|
| 50MG | 63 | Get Quote |
|
| 100MG | 96 | Get Quote |
|
| 500MG | 155 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDoxycycline monohydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionDoxycycline monohydrate is an inhibitor of metalloproteinase (MMP).
-
DescriptionDoxycycline monohydrate is an inhibitor of metalloproteinase (MMP)?.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorMMP
-
Research AreaOthers
-
Indicationrickettsiosis
Chemical Information
-
CAS Number17086-28-1
-
Formula Weight462.4
-
Molecular FormulaC22H26N2O9
-
Purity>98% (HPLC)
-
SolubilityDMSO:47 mg/mL (11.63 mM)
-
SMILESC[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O
-
Chemical Name4-(Dimethylamino)-144a55a61112a-octahydro-35101212a-pentahydroxy-6-methyl-111-dioxo-2-naphthacenecarboxamide monohydrate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Briest W Cooper T K Tae H J et al. Doxycycline Ameliorates the Susceptibility to Aortic Lesions in a Mouse Model for the Vascular Type of Ehlers-Danlos Syndrome[J]. Journal of Pharmacology & Experimental Therapeutics 2011 337(3):621-627.
molnova catalog
related products
-
PG-116800
PG-116800 (PG-530742) is a matrix metalloproteinase (MMP) inhibitor. PG-116800 can be used in studies about the treatment of osteoarthritis.
-
Pectolinarigenin
Pectolinarigenin possesses anti-inflammatory activity and that they may inhibit eicosanoid formation in inflammatory lesions.
-
Andecaliximab
Andecaliximab is a recombinant IgG4 monoclonal antibody targeting matrix metalloproteinase 9 (MMP9). Andecaliximab showed antifibrotic effects in a mouse model of idiopathic pulmonary fibrosis.
